ORAL CONTRIBUTED SESSION 27: Competing Risks II
Tracks
PARALLEL HALL 3 (Museum Hall)
| Wednesday, July 24, 2024 |
| 2:00 PM - 3:32 PM |
| PARALLEL HALL 3 (Museum Hall) |
Presentations
Dr. Serigne Lo
Head Of Research & Biostatistics
University of Sydney / Melanoma Institute Australia
OC27-1 | Mixture cure cause-specific hazard Cox models for competing risks data with partly interval censoring
2:00 PM - 2:18 PM
Dr. Jagathnath Krishna Kumarapillai Mohanan Nair
Associate Professor
Regional Cancer Centre, Thiruvananthapuram, India
OC27-2 | Joint frailty modelling of multiple time-to-events and longitudinal measures
2:18 PM - 2:36 PM
Ms. Ilse Cuevas Andrade
University College London
OC27-3 | Non-parametric frailty model for the natural history of prostate cancer; using data from a screening trial
2:36 PM - 2:54 PM
Dr. Liesbeth de Wreede
Leiden UMC, Netherlands
OC27-4 | Dynamics of excess mortality during the Covid-19 pandemic in the Netherlands – Impact of vaccination and infection analysed through a multi-state model incorporating relative survival
2:54 PM - 3:12 PM
Ms. Haoning Shen
Southern Medical University, Guangzhou, China
OC27-5 | Assessing treatment effects with adjusted restricted mean time lost in observational competing risks data
3:12 PM - 3:30 PMChair
Nadine Binder
Universitätsklinikum Freiburg, Germany
